Sign inGet started

Damaj Bassam

Insider CIK 1478733 · APRI President and CEO, Director · INNV President and CEO, Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
INNV INNOVUS PHARMACEUTICALS, I A Award deriv2016-11-162016-11-212,000,000$0.25 $500.0K7,875,000SEC↗
INNV INNOVUS PHARMACEUTICALS, I A Award deriv2016-01-292016-02-024,000,000— $05,875,000SEC↗
INNV INNOVUS PHARMACEUTICALS, I A Award2015-06-262015-06-2950$0.12 $66,852,322SEC↗
INNV INNOVUS PHARMACEUTICALS, I A Award deriv2015-03-312015-04-014,500,000— $04,500,000SEC↗
INNV INNOVUS PHARMACEUTICALS, I C Conversion2014-02-192014-02-211,190,411— $01,708,265SEC↗
INNV INNOVUS PHARMACEUTICALS, I A Award deriv2014-02-062014-02-10852,272— $06,852,272SEC↗
INNV INNOVUS PHARMACEUTICALS, I G Gift2013-09-092014-02-1020,000— $0517,854SEC↗
INNV INNOVUS PHARMACEUTICALS, I P Buy2013-06-122013-06-14287,448$0.32 $92.0K5,051,270SEC↗
INNV INNOVUS PHARMACEUTICALS, I P Buy2013-06-122013-06-14129,393$0.32 $41.4K129,393SEC↗
INNV INNOVUS PHARMACEUTICALS, I A Award deriv2013-02-152013-02-196,000,000— $06,000,000SEC↗
INNV INNOVUS PHARMACEUTICALS, I P Buy2013-02-022013-02-05250,406$0.48 $120.2K250,406SEC↗
INNV INNOVUS PHARMACEUTICALS, I P Buy2013-02-022013-02-13250,406$0.48 $120.2K3,459,877SEC↗
APRI APRICUS BIOSCIENCES, INC. O Exercise OTM2012-08-232012-08-23249,002— $01,610,987SEC↗
APRI APRICUS BIOSCIENCES, INC. P Buy2012-08-212012-08-23760$2.77 $2.1K1,611,747SEC↗
APRI APRICUS BIOSCIENCES, INC. P Buy2012-08-202012-08-211,500$2.69 $4.0K1,361,985SEC↗
APRI APRICUS BIOSCIENCES, INC. A Award deriv2012-03-052012-03-07200,000— $0200,000SEC↗
APRI APRICUS BIOSCIENCES, INC. J Other2011-06-142012-03-2834,342— $0825,445SEC↗
APRI APRICUS BIOSCIENCES, INC. J Other2011-06-142012-03-2890,167— $0535,040SEC↗